Cigna Quarterly Income Statements Chart
Quarterly
|
Annual
Cigna Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues | ||||||||||||||||||||||||||
pharmacy revenues | 53,649,000,000 | 48,633,000,000 | 33,855,250,000 | 48,284,000,000 | 45,101,000,000 | 42,036,000,000 | 25,159,750,000 | 34,531,000,000 | 33,964,000,000 | 32,144,000,000 | 33,135,000,000 | 32,762,000,000 | 31,972,000,000 | 30,697,000,000 | 32,328,000,000 | 31,013,000,000 | 30,047,000,000 | 28,025,000,000 | 28,305,000,000 | 27,802,000,000 | 26,564,000,000 | 25,098,000,000 | 19,363,500,000 | 25,987,000,000 | 26,288,000,000 | 25,179,000,000 |
premiums | 9,156,000,000 | 12,736,000,000 | 8,623,250,000 | 11,436,000,000 | 11,454,000,000 | 11,603,000,000 | 8,265,500,000 | 10,998,000,000 | 11,039,000,000 | 11,025,000,000 | 9,547,000,000 | 9,586,000,000 | 10,426,000,000 | 10,356,000,000 | 10,342,000,000 | 10,275,000,000 | 10,323,000,000 | 10,214,000,000 | 10,699,000,000 | 10,682,000,000 | 10,406,000,000 | 10,840,000,000 | 7,427,250,000 | 9,935,000,000 | 9,803,000,000 | 9,971,000,000 |
fees and other revenues | 4,137,000,000 | 3,895,000,000 | 2,715,500,000 | 3,889,000,000 | 3,647,000,000 | 3,326,000,000 | 2,393,500,000 | 3,198,000,000 | 3,305,000,000 | 3,071,000,000 | 2,857,000,000 | 2,728,000,000 | 2,757,000,000 | 2,538,000,000 | 2,638,000,000 | 2,532,000,000 | 2,451,000,000 | 2,341,000,000 | 2,337,000,000 | 2,174,000,000 | 2,072,000,000 | 2,178,000,000 | 1,780,750,000 | 2,285,000,000 | 2,388,000,000 | 2,450,000,000 |
net investment income | 236,000,000 | 238,000,000 | 174,000,000 | 85,000,000 | 321,000,000 | 290,000,000 | -854,000,000 | 321,000,000 | 278,000,000 | 277,000,000 | 212,000,000 | 204,000,000 | 325,000,000 | 414,000,000 | 380,000,000 | 468,000,000 | 310,000,000 | 391,000,000 | 371,000,000 | 297,000,000 | 223,000,000 | 353,000,000 | 258,750,000 | 349,000,000 | 340,000,000 | 346,000,000 |
total revenues | 67,178,000,000 | 65,502,000,000 | -180,977,000,000 | 63,694,000,000 | 60,523,000,000 | 57,255,000,000 | -143,613,000,000 | 49,048,000,000 | 48,586,000,000 | 46,517,000,000 | 45,751,000,000 | 45,280,000,000 | 45,480,000,000 | 44,005,000,000 | 45,688,000,000 | 44,288,000,000 | 43,131,000,000 | 40,971,000,000 | 41,712,000,000 | 40,955,000,000 | 39,265,000,000 | 38,469,000,000 | 38,245,000,000 | 38,556,000,000 | 38,819,000,000 | 37,946,000,000 |
benefits and expenses | ||||||||||||||||||||||||||
pharmacy and other service costs | 53,268,000,000 | 48,398,000,000 | 33,372,000,000 | 47,565,000,000 | 44,492,000,000 | 41,431,000,000 | 24,635,000,000 | 33,639,000,000 | 33,442,000,000 | 31,459,000,000 | 32,094,000,000 | 31,777,000,000 | 31,150,000,000 | 29,813,000,000 | 31,247,000,000 | 30,070,000,000 | 29,001,000,000 | 27,235,000,000 | 27,059,000,000 | 26,624,000,000 | 25,611,000,000 | 24,190,000,000 | 18,391,250,000 | 24,552,000,000 | 24,963,000,000 | 24,050,000,000 |
medical costs and other benefit expenses | 7,749,000,000 | 10,498,000,000 | 7,120,500,000 | 9,527,000,000 | 9,515,000,000 | 9,440,000,000 | 6,751,750,000 | 8,927,000,000 | 9,034,000,000 | 9,046,000,000 | 7,992,000,000 | 7,754,000,000 | 8,192,000,000 | 8,268,000,000 | 8,743,000,000 | 8,330,000,000 | 8,484,000,000 | 8,005,000,000 | 8,847,000,000 | 8,429,000,000 | 7,112,000,000 | 8,322,000,000 | 5,732,500,000 | 7,734,000,000 | 7,576,000,000 | 7,620,000,000 |
selling, general and administrative expenses | 3,433,000,000 | 4,213,000,000 | -10,965,000,000 | 3,590,000,000 | 3,684,000,000 | 3,705,000,000 | -10,758,000,000 | 3,788,000,000 | 3,434,000,000 | 3,538,000,000 | 3,483,000,000 | 3,148,000,000 | 3,256,000,000 | 3,299,000,000 | 3,662,000,000 | 3,093,000,000 | 2,996,000,000 | 3,279,000,000 | 3,966,000,000 | 3,301,000,000 | 3,407,000,000 | 3,398,000,000 | 2,524,000,000 | 3,413,000,000 | 3,380,000,000 | 3,303,000,000 |
amortization of acquired intangible assets | 422,000,000 | 422,000,000 | 319,750,000 | 436,000,000 | 420,000,000 | 423,000,000 | 342,000,000 | 454,000,000 | 455,000,000 | 459,000,000 | 457,000,000 | 460,000,000 | 501,000,000 | 458,000,000 | 499,000,000 | 501,000,000 | 503,000,000 | 495,000,000 | 495,000,000 | 493,000,000 | 496,000,000 | 498,000,000 | -2,214,002,949 | 734,000,000 | 737,000,000 | 743,000,000 |
total benefits and expenses | 64,872,000,000 | 63,531,000,000 | 43,557,000,000 | 61,118,000,000 | 58,111,000,000 | 54,999,000,000 | 34,418,750,000 | 46,808,000,000 | 46,365,000,000 | 44,502,000,000 | 44,026,000,000 | 43,139,000,000 | 43,099,000,000 | 41,838,000,000 | 44,151,000,000 | 41,994,000,000 | 40,984,000,000 | 39,014,000,000 | 40,367,000,000 | 38,847,000,000 | 36,626,000,000 | 36,408,000,000 | 27,201,250,000 | 36,433,000,000 | 36,656,000,000 | 35,716,000,000 |
income from operations | 2,306,000,000 | 1,971,000,000 | -6,763,000,000 | 2,576,000,000 | 2,412,000,000 | 2,256,000,000 | -5,940,000,000 | 2,240,000,000 | 2,221,000,000 | 2,015,000,000 | 1,725,000,000 | 2,141,000,000 | 2,381,000,000 | 2,167,000,000 | 1,537,000,000 | 2,294,000,000 | 2,147,000,000 | 1,957,000,000 | 1,345,000,000 | 2,108,000,000 | 2,639,000,000 | 2,061,000,000 | 1,629,000,000 | 2,123,000,000 | 2,163,000,000 | 2,230,000,000 |
yoy | -4.39% | -12.63% | 13.86% | 15.00% | 8.60% | 11.96% | -444.35% | 4.62% | -6.72% | -7.01% | 12.23% | -6.67% | 10.90% | 10.73% | 14.28% | 8.82% | -18.64% | -5.05% | -17.43% | -0.71% | 22.01% | -7.58% | ||||
qoq | 17.00% | -129.14% | -362.54% | 6.80% | 6.91% | -137.98% | -365.18% | 0.86% | 10.22% | 16.81% | -19.43% | -10.08% | 9.88% | 40.99% | -33.00% | 6.85% | 9.71% | 45.50% | -36.20% | -20.12% | 28.04% | 26.52% | -23.27% | -1.85% | -3.00% | |
operating margin % | ||||||||||||||||||||||||||
interest expense and other | -337,000,000 | -362,000,000 | -315,000,000 | -376,000,000 | -375,000,000 | -322,000,000 | -271,500,000 | -365,000,000 | -363,000,000 | -358,000,000 | -324,000,000 | -304,000,000 | -301,000,000 | -299,000,000 | -293,000,000 | -303,000,000 | -298,000,000 | -314,000,000 | -337,000,000 | -336,000,000 | -374,000,000 | -391,000,000 | -322,750,000 | -411,000,000 | -428,000,000 | -452,000,000 |
gain on sale of businesses | 41,000,000 | -5,250,000 | -21,000,000 | -73,000,000 | 1,735,000,000 | |||||||||||||||||||||
net investment gains | 52,000,000 | |||||||||||||||||||||||||
income before income taxes | 2,021,000,000 | 1,648,000,000 | -4,169,000,000 | 1,192,000,000 | 1,989,000,000 | 79,000,000 | -6,239,000,000 | 1,840,000,000 | 1,884,000,000 | 1,601,000,000 | 1,328,000,000 | 3,491,000,000 | 1,985,000,000 | 1,549,000,000 | 1,312,000,000 | 2,059,000,000 | 1,898,000,000 | 1,513,000,000 | 5,378,000,000 | 1,804,000,000 | 2,289,000,000 | 1,397,000,000 | -5,308,993,430 | 1,763,000,000 | 1,758,000,000 | 1,788,000,000 |
total income taxes | 389,000,000 | 239,000,000 | 254,500,000 | 367,000,000 | 360,000,000 | 291,000,000 | 265,000,000 | 391,000,000 | 374,000,000 | 295,000,000 | 130,000,000 | 713,000,000 | 413,000,000 | 351,000,000 | 179,000,000 | 424,000,000 | 422,000,000 | 342,000,000 | 1,236,000,000 | 406,000,000 | 529,000,000 | 208,000,000 | 293,250,000 | 409,000,000 | 348,000,000 | 416,000,000 |
net income | 1,632,000,000 | 1,409,000,000 | 560,500,000 | 825,000,000 | 1,629,000,000 | -212,000,000 | 1,066,250,000 | 1,449,000,000 | 1,510,000,000 | 1,306,000,000 | 1,198,000,000 | 2,778,000,000 | 1,572,000,000 | 1,198,000,000 | 1,133,000,000 | 1,635,000,000 | 1,476,000,000 | 1,171,000,000 | 4,142,000,000 | 1,398,000,000 | 1,760,000,000 | 1,189,000,000 | 1,034,000,000 | 1,354,000,000 | 1,410,000,000 | 1,372,000,000 |
yoy | 0.18% | -764.62% | -47.43% | -43.06% | 7.88% | -116.23% | -11.00% | -47.84% | -3.94% | 9.02% | 5.74% | 69.91% | 6.50% | 2.31% | -72.65% | 16.95% | -16.14% | -1.51% | 300.58% | 3.25% | 24.82% | -13.34% | ||||
qoq | 15.83% | 151.38% | -32.06% | -49.36% | -868.40% | -119.88% | -26.41% | -4.04% | 15.62% | 9.02% | -56.88% | 76.72% | 31.22% | 5.74% | -30.70% | 10.77% | 26.05% | -71.73% | 196.28% | -20.57% | 48.02% | 14.99% | -23.63% | -3.97% | 2.77% | |
net income margin % | ||||||||||||||||||||||||||
less: net income attributable to noncontrolling interests | 100,000,000 | 86,000,000 | 58,000,000 | 86,000,000 | 81,000,000 | 65,000,000 | 32,500,000 | 41,000,000 | 50,000,000 | 39,000,000 | 29,000,000 | 21,000,000 | 13,000,000 | 15,000,000 | 17,000,000 | 14,000,000 | 9,000,000 | 10,000,000 | 7,000,000 | 10,000,000 | 6,000,000 | 8,000,000 | 2,250,000 | 3,000,000 | 2,000,000 | 4,000,000 |
shareholders' net income | 1,532,000,000 | 1,323,000,000 | -277,000,000 | 1,029,000,000 | 1,408,000,000 | 1,460,000,000 | 1,267,000,000 | 1,169,000,000 | 2,757,000,000 | 1,559,000,000 | 1,183,000,000 | 1,116,000,000 | 1,621,000,000 | 1,467,000,000 | 1,161,000,000 | |||||||||||
shareholders' net income per share | ||||||||||||||||||||||||||
basic | 5.76 | 4.88 | 1.783 | 2.65 | 5.51 | -0.97 | 3.508 | 4.79 | 4.96 | 4.28 | 3.94 | 9.07 | 4.95 | 3.71 | ||||||||||||
diluted | 5.71 | 4.85 | 1.763 | 2.63 | 5.45 | -0.97 | 3.473 | 4.74 | 4.92 | 4.24 | 3.88 | 8.97 | 4.9 | 3.68 | ||||||||||||
net investment losses | -2,000,000 | |||||||||||||||||||||||||
loss on sale of businesses | -26,500,000 | -87,000,000 | -19,000,000 | |||||||||||||||||||||||
net realized investment losses | -701,250,000 | -921,000,000 | -1,836,000,000 | -11,000,000 | -14,000,000 | -56,000,000 | ||||||||||||||||||||
shareholders’ net income | 502,500,000 | 739,000,000 | 1,548,000,000 | 1,080,750,000 | 1,388,000,000 | 1,754,000,000 | 1,181,000,000 | 977,000,000 | 1,351,000,000 | 1,408,000,000 | 1,368,000,000 | |||||||||||||||
net realized investment gains | -48,000,000 | 26,000,000 | -81,000,000 | -95,000,000 | -319,000,000 | 68,000,000 | 68,000,000 | 59,000,000 | 1,000,000 | 167,000,000 | 32,000,000 | 38,000,000 | -88,000,000 | 21,000,000 | 51,000,000 | 23,000,000 | 10,000,000 | |||||||||
debt extinguishment costs | -10,000,000 | -131,000,000 | -14,000,000 | -185,000,000 | ||||||||||||||||||||||
shareholders’ net income per share | ||||||||||||||||||||||||||
basic | 3.11 | 4.84 | 4.3 | 3.33 | 11.4 | 3.81 | 4.77 | 3.19 | 2.735 | 3.6 | 3.73 | 3.61 | ||||||||||||||
diluted | 3.08 | 4.8 | 4.25 | 3.3 | 11.3 | 3.78 | 4.73 | 3.15 | 2.708 | 3.57 | 3.7 | 3.56 | ||||||||||||||
the accompanying notes to the consolidated financial statements (unaudited) are an integral part of these statements. |
We provide you with 20 years income statements for Cigna stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Cigna stock. Explore the full financial landscape of Cigna stock with our expertly curated income statements.
The information provided in this report about Cigna stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.